Healthcare -
Biotechnology - NASDAQ - US
$ 12.69
1.2 %
$ 475 M
Market Cap
8.81
P/E
TRDA - DEPRECIATION & AMORTIZATION
Depreciation & Amortization TRDA - Entrada Therapeutics, Inc.
2.84 M
LAST VALUE
59.48%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR